Results from the gene-wise association test (using the gene-wise approach of the combined burden and variance-component test SKAT-O) for rare variants of Tier 1–3 genes and functionally validated variants of the SCN9A, SCN10A, SCN11A genes for all participants with neuropathic pain. The gene discussed is SCN9A; the disease is neuropathic pain.